Gaelic Laboratories has acquired Athlone Laboratories in a move aimed at strengthening its market position in the production of Beta-Lactam medicines. The company said the deal enhances manufacturing capabilities, supports supply chain efficiency and aligns with its long-term growth strategy
PolyPeptide Group has formed a strategic alliance with Lupin Manufacturing Solutions Limited to enhance supply chain resilience and operational efficiency for peptide-based active pharmaceutical ingredients. The companies said the agreement will broaden PolyPeptide’s sourcing options for key materials and create
TNAX Biopharma has entered into a strategic collaboration with Chime Biologics to support the development of TNAX103, a humanised anti-CD300A monoclonal antibody. The companies described the partnership as a milestone that establishes Chime Biologics’ first project in Japan and reflects
Lindus Health and Quotient Sciences have announced a strategic partnership designed to strengthen patient recruitment in early-phase clinical studies and create a more seamless path from first-in-human to proof-of-concept trials. The companies said the collaboration addresses inefficiencies created when sponsors
uBriGene Biosciences has announced a strategic partnership with Circurna to support the development and manufacturing of next-generation circular RNA therapeutics. The companies said the agreement will integrate uBriGene’s end-to-end process development, analytical services and GMP production capabilities with Circurna’s proprietary
CHA Biotech’s CDMO subsidiary Matica Biolabs has signed a contract development and manufacturing deal with TiCARos to produce clinical trial material for the biotech’s solid tumour–focused CAR-T therapy. The agreement centres on TC091, a candidate built on TiCARos’ proprietary CLIP
Tivic Health has acquired the strategic manufacturing and development assets of Scorpius Holdings and launched Velocity Bioworks, a wholly owned subsidiary that will provide contract development and manufacturing services to Tivic and other biotechnology companies. The company said the initiative
Tjoapack has announced a strategic investment to expand its operational footprint in the United States with the development of a new 170,000-square-foot facility in Clinton, Tennessee. The project is scheduled for completion in early 2027 and is designed to meet
Akadeum Life Sciences has launched the Akadeum CDMO Alliance™, a new consortium designed to support innovation in cell therapy manufacturing by integrating microbubble-based cell separation technologies with partner CDMOs. Charles River and ElevateBio have been named as the first two
AST has entered a strategic partnership with the Marchesini Group to enhance global capabilities in sterile fill-finish and drug product manufacturing. The companies said the agreement combines technology, expertise, and distribution infrastructures to deliver more integrated solutions across major global
